Fmr LLC Regeneron Pharmaceuticals, Inc. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Fmr LLC holds 10,649,474 shares of REGN stock, worth $12 Billion. This represents 0.74% of its overall portfolio holdings.

Number of Shares

10,649,474

Previous 10,794,072 1.34%

Holding current value

$12 Billion

Previous $10.4 Billion 7.74%

% of portfolio

0.74%

Previous 0.72%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$883.2 - $1071.19 $128 Million - $155 Million	-144,598 Reduced 1.34%	10,649,474 $11.2 Billion
Q1 2024 May 13, 2024	BUY	$902.69 - $993.35 $430 Million - $473 Million	476,657 Added 4.62%	10,794,072 $10.4 Billion
Q4 2023 Feb 13, 2024	BUY	$775.18 - $881.7 $369 Million - $420 Million	476,523 Added 4.84%	10,317,415 $9.06 Billion
Q3 2023 Nov 13, 2023	BUY	$692.45 - $844.37 $464 Million - $565 Million	669,517 Added 7.3%	9,840,892 $8.1 Billion
Q2 2023 Aug 11, 2023	SELL	$700.03 - $830.35 $188 Million - $223 Million	-268,721 Reduced 2.85%	9,171,375 $6.59 Billion
Q1 2023 May 11, 2023	SELL	$680.49 - $826.97 $1.13 Billion - $1.37 Billion	-1,656,895 Reduced 14.93%	9,440,096 $7.76 Billion
Q4 2022 Feb 13, 2023	BUY	$705.89 - $766.39 $203 Million - $220 Million	287,245 Added 2.66%	11,096,991 $8.01 Billion
Q3 2022 Nov 10, 2022	BUY	$573.97 - $724.32 $364 Million - $459 Million	633,547 Added 6.23%	10,809,746 $7.45 Billion
Q2 2022 Aug 12, 2022	BUY	$548.35 - $738.84 $106 Million - $143 Million	193,175 Added 1.94%	10,176,199 $6.02 Billion
Q1 2022 May 13, 2022	SELL	$595.12 - $698.43 $47.6 Million - $55.8 Million	-79,943 Reduced 0.79%	9,983,024 $6.97 Billion
Q4 2021 Feb 14, 2022	SELL	$543.48 - $670.97 $546 Million - $674 Million	-1,004,984 Reduced 9.08%	10,062,967 $6.35 Billion
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $90.3 Million - $107 Million	157,257 Added 1.44%	11,067,951 $6.7 Billion
Q2 2021 Aug 13, 2021	BUY	$472.8 - $558.54 $5.16 Billion - $6.09 Billion	10,910,694 New	10,910,694 $6.09 Billion

Others Institutions Holding REGN

# of Institutions

1,460

Shares Held

84.5M

Call Options Held

907K

Put Options Held

1.3M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $121B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account